NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
NeoGenomics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
NeoGenomics's operating income for the twelve months ending Sep 30, 2026 was -$49.37M. For fiscal 2025 it was -$115.88M. The highest annual figure on record is $13.01M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$115.88M | – |
| FY2024 | Dec 31, 2024 | -$92.11M | – |
| FY2023 | Dec 31, 2023 | -$107.74M | – |
| FY2022 | Dec 31, 2022 | -$157.62M | – |
| FY2021 | Dec 31, 2021 | -$118.75M | – |
| FY2020 | Dec 31, 2020 | -$13.99M | -207.6% |
| FY2019 | Dec 31, 2019 | $13.01M | +29.5% |
| FY2018 | Dec 31, 2018 | $10.04M | +246.0% |
| FY2017 | Dec 31, 2017 | $2.90M | +34.7% |
| FY2016 | Dec 31, 2016 | $2.16M | – |
| FY2015 | Dec 31, 2015 | -$5.64M | -354.1% |
| FY2014 | Dec 31, 2014 | $2.22M | -30.1% |
| FY2013 | Dec 31, 2013 | $3.17M | +162.1% |
| FY2012 | Dec 31, 2012 | $1.21M | – |
| FY2011 | Dec 31, 2011 | -$409.00K | – |
| FY2010 | Dec 31, 2010 | -$2.96M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$7.94M | – |
| Q2 FY2026 | Jun 30, 2026 | -$9.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$27.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$47.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.83M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.57M | – |
| Q3 FY2023 | Sep 30, 2023 | -$24.20M | – |
| Q2 FY2023 | Jun 30, 2023 | -$29.89M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.07M | – |
| Q4 FY2022 | Dec 31, 2022 | -$26.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$39.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$52.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$41.57M | -850.4% |
| Q3 FY2021 | Sep 30, 2021 | -$39.71M | -950.6% |
| Q2 FY2021 | Jun 30, 2021 | -$22.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.11M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.54M | +138.6% |
| Q3 FY2020 | Sep 30, 2020 | $4.67M | +27.6% |
| Q2 FY2020 | Jun 30, 2020 | -$18.91M | -522.2% |
| Q1 FY2020 | Mar 31, 2020 | -$5.29M | -307.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.32M | -17.7% |
| Q3 FY2019 | Sep 30, 2019 | $3.66M | -6.7% |
| Q2 FY2019 | Jun 30, 2019 | $4.48M | +464.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.55M | +1.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.82M | -23.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.92M | – |
| Q2 FY2018 | Jun 30, 2018 | $794.00K | -56.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.51M | – |
| Q4 FY2017 | Dec 31, 2017 | $3.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.06M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.84M | – |
| Q1 FY2017 | Mar 31, 2017 | -$580.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.35M | – |
See a number that looks wrong?